Zobrazeno 1 - 10
of 39
pro vyhledávání: '"M. F. Di Renzo"'
Preclinical immunotherapy with Cytokine-Induced Killer lymphocytes against epithelial ovarian cancer
Autor:
Eleonora Ghisoni, Dario Sangiolo, Giorgio Valabrega, Massimo Aglietta, Sonia Capellero, Jessica Erriquez, C Melano, Martina Olivero, Giulia Mesiano, M. F. Di Renzo, Gloria Mittica, Alberto Pisacane, Sofia Genta
Publikováno v:
Scientific Reports
Scientific Reports, Vol 10, Iss 1, Pp 1-11 (2020)
Scientific Reports, Vol 10, Iss 1, Pp 1-11 (2020)
Despite improvements in surgery and medical treatments, epithelial ovarian cancer (EOC) remains the most lethal gynaecological malignancy. Aim of this study is to investigate the preclinical immunotherapy activity of cytokine-induced killer lymphocyt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dab7ed0a7fb323279e2d865882ad1d5f
https://pubmed.ncbi.nlm.nih.gov/32296104
https://pubmed.ncbi.nlm.nih.gov/32296104
Autor:
Giorgio Valabrega, Annamaria Ferrero, E.M. Canuto, Anna Sapino, P. Bruna, L. Verdun di Cantogno, Martina Olivero, M. F. Di Renzo, Massimo Aglietta, Furio Maggiorotto, Maria Stella Scalzo, Jessica Erriquez, P. Becco, Riccardo Ponzone
Publikováno v:
Gynecologic Oncology. 138:627-633
Objective The treatment of platinum resistant/refractory epithelial ovarian cancer (EOC) is a challenge for oncologists. One of the most utilized drugs in these patients is pegylated liposomal doxorubicin (PLD). As PLD is active only in a small subse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::82fe6bfb6ee0142dc44c5d718c47f03e
https://doi.org/10.1016/j.ygyno.2015.06.025
https://doi.org/10.1016/j.ygyno.2015.06.025
Autor:
J, Erriquez, P, Becco, M, Olivero, R, Ponzone, F, Maggiorotto, A, Ferrero, M S, Scalzo, E M, Canuto, A, Sapino, L, Verdun di Cantogno, P, Bruna, M, Aglietta, M F, Di Renzo, G, Valabrega
The treatment of platinum resistant/refractory epithelial ovarian cancer (EOC) is a challenge for oncologists. One of the most utilized drugs in these patients is pegylated liposomal doxorubicin (PLD). As PLD is active only in a small subset of patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::e6e918fcd76ac6f1471031ee178775a0
http://hdl.handle.net/2318/1522069
http://hdl.handle.net/2318/1522069
Autor:
F De Bacco, Pm Comoglio, M. F. Di Renzo, Lorenza D'Alessandro, Daniela Gramaglia, Michela Fassetta, Andrea Rasola
Publikováno v:
Oncogene. 26:1078-1087
Overexpressed or activated hepatocyte growth factor receptor, encoded by the MET proto-oncogene, was found in the majority of colorectal carcinomas (CRCs), whose stepwise progression to malignancy requires transcriptional activation of beta-catenin.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bedca0072c82b31ded31473a5b6dae96
https://doi.org/10.1038/sj.onc.1209859
https://doi.org/10.1038/sj.onc.1209859
Autor:
Martina Olivero, Sid Berrone, M. Bernardi, Mario Aimetti, Silvia Giordano, S. Morello, M. F. Di Renzo
Publikováno v:
Journal of Cellular Physiology. 189:285-290
Oral squamous cell carcinoma (SCC) is a neoplasm characterized by a high degree of local invasion and an elevated rate of metastasis to cervical lymph nodes. It has been shown that the Hepatocyte Growth Factor/Scatter Factor Receptor Met is constitut
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5fb56fa0c07edc9c44cb01de53a9d2c
https://doi.org/10.1002/jcp.10010
https://doi.org/10.1002/jcp.10010
Autor:
Pietro Gangemi, G M Santonocito, A. Belfiore, Orazio Ippolito, A. Fiumara, A. Costantino, Giovanna Russo, M. F. Di Renzo, Paolo M. Comoglio, Riccardo Vigneri
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 82:2322-2328
To investigate the clinical impact of Met/hepatocyte growth factor receptor (HGF-R) expression in thyroid cancer we studied 163 thyroid carcinomas (129 papillary, 21 follicular, and 13 anaplastic) from patients followed-up for 25-147 months postthyro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::64bb8ac40fd18d67a358e9364fff6f3d
https://doi.org/10.1210/jcem.82.7.4104
https://doi.org/10.1210/jcem.82.7.4104
Autor:
G, Cortesina, T, Martone, E, Galeazzi, M, Olivero, A, De Stefani, M, Bussi, G, Valente, P M, Comoglio, M F, Di Renzo
In head and neck squamous cell carcinomas (HNSCC), metastasis to cervical lymph nodes is a major determinant of patient outcome. To detect metastases, we used the MET oncogene as marker, which encodes the receptor for hepatocyte growth factor/scatter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::fe60b10a5eefa2da676615f7f749ee0e
Publikováno v:
Scopus-Elsevier
The usefulness of phosphotyrosine antibodies for the detection of physiologically regulated or deregulated tyrosine kinases is discussed in this report. This rather rare enzymatic activity is shared by receptors for some polypeptide growth factors an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8cf938bfd68a7fcc38969fd194dc9ee
https://doi.org/10.1164/ajrccm/142.6_pt_2.s16
https://doi.org/10.1164/ajrccm/142.6_pt_2.s16
Somatic mutations of the MET oncogene are selected during metastatic spread of human HNSC carcinomas
Autor:
Paolo M. Comoglio, Silvia Giordano, Piera Maggiora, Martina Olivero, M. F. Di Renzo, Tiziana Martone, Guido Valente, A. De Stefani, Antonella Maffe, Giorgio Cortesina
Publikováno v:
Scopus-Elsevier
A metastatic cancer develops by accumulation of mutations in genes that control growth, survival and spreading. The latter genes have not yet been identified. In lymph node metastases of head and neck squamous cell carcinomas (HNSCC), we found mutati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ea4d7a8b5e2b8cbf3489e2f2883998a
http://hdl.handle.net/2318/154451
http://hdl.handle.net/2318/154451